Metabolic researchIn stock — dispatched same-day before 2pm
Retatrutide Vial 20 mg
Triple agonist research peptide, 20 mg lyophilised vial
Triple-receptor agonismComparative metabolic studiesGlucagon-pathway research
£101.77SKU: RTV-20
1
In stock — dispatched same-day before 2pm
Purity
≥ 99% (HPLC)
Format
Lyophilised vial
Batch ref.
Assigned at dispatchCertificate of Analysis includedUK & EU cold-chain dispatchIn vitro research use only
Research pathwayRetatrutide Vial 20 mg · catalogued focus areas
Triple-receptor agonismComparative metabolic studiesGlucagon-pathway research
3 active research areas · ≥ 99% (HPLC)Batch assigned at dispatch
Research description
Retatrutide is a next-generation triple agonist (GLP-1 / GIP / glucagon) research peptide. This format is a lyophilised 20 mg vial, reconstituted before use. A Certificate of Analysis accompanies every batch. In vitro laboratory research use only.
- 20 mg lyophilised vial for in-lab reconstitution
- Triple agonist spanning GLP-1, GIP and glucagon receptors
- Independent CoA matched to every batch reference
Regulatory notice
This product is supplied strictly for in vitro laboratory and analytical research. It is not intended for human or veterinary use, and is not a drug, food, or cosmetic under UK or EU law.
Read the full disclaimer→
